ARCH Venture Partners

Venture Capital

Deep Science & Academic Spinouts

Chicago, United States · 217+ investments · 129 portfolio companies

Seed
Early Stage
Deep Tech
Headquarters
Chicago, United States
AUM
$9.4B
Portfolio Companies
129
Total Investments
217
Last Investment
Jul 2026
Geographic Focus
United States

Investment Thesis

Co-founds and backs deep science companies at the earliest stages, partnering directly with university researchers and scientists to commercialize breakthrough discoveries in life sciences, biotech, and deep tech.

ARCH Venture Partners is a Venture Capital firm based in Chicago, United States. It has made 217 investments in Deep Tech, including ONI, Moleculent AB and GRAIL.

Portfolio129

O
ONI
Moleculent AB
GRAIL
Twist Bioscience
Walden Biosciences
Rippl
Magnet Biomedicine
Karuna Therapeutics
Sironax
Bitterroot Bio
Lightcast Discovery
JT
Juno Therapeutics
Encoded Therapeutics
Rome Therapeutics
Matter Neuroscience
Gate Bioscience
Parabilis Medicines
Orbital Therapeutics
Vir Biotechnology
Quantum Circuits
Lilac Therapeutics
Cytrellis Biosystems
Dewpoint Therapeutics
Carrick Therapeutics
Lifordi Immunotherapeutics
Illumina
nChroma Bio
SonoThera
BE Biopharma
City Therapeutics
RhyGaze
eGenesis
Areteia Therapeutics
hC Bioscience
Xaira Therapeutics
Generate Biomedicines
Qihan Biotech
Pheast Therapeutics
Curie.Bio
LifeMine Therapeutics
Autobahn Therapeutics
Mirador Therapeutics
Transcenta Holding
Denali Therapeutics
Remix Therapeutics
SunBird Bio
Volastra Therapeutics
Accompany Health

Investment History

Sign up to view investment history

Create a free account — 10 credits a month to unlock deal history, amounts, and round details.